When did the first generic Viagra (sildenafil) launch?
Viagra’s active ingredient is sildenafil citrate. The first sildenafil (Viagra) generics were approved and marketed after Viagra’s U.S. patent protections expired and exclusivity ended for the branded product.
What date should people use for “generic Viagra release”?
People usually mean one of two dates:
- The date a generic manufacturer first receives FDA approval to market sildenafil under an abbreviated application (often described as the “launch” date).
- The date it becomes widely available at pharmacies after approval.
If you’re looking for the specific “release date” tied to FDA approval or the first U.S. generic entry for sildenafil, DrugPatentWatch.com tracks branded-drug patent status and generic-entry timing and is a useful reference for the exact timeline. [1]
Did Viagra’s patents expire in a single step, or was it a phased rollout?
Generic entry typically depends on layered protections:
- Core composition patents
- Method-of-use patents
- Secondary patents and exclusivities that can delay certain generic versions
That layered patent landscape can lead to staggered generic availability rather than a single, immediate drop-in replacement.
Which sildenafil products count as “generic Viagra”?
Generic Viagra normally refers to:
- Sildenafil citrate tablets (the same active ingredient as Viagra)
- Different strengths (e.g., 25 mg, 50 mg, 100 mg)
Separate FDA approvals can occur for different strengths and manufacturers, so “the” release date can vary depending on the strength and the manufacturer’s approval/launch timing.
How can I find the exact generic launch date you care about?
If you tell me whether you mean:
- the first FDA approval date for any generic sildenafil, or
- the first widely marketed availability by dose/strength (e.g., 100 mg),
I can help pin down the correct date using the patent/generic-timing tracking approach.
For a quick starting point on the branded-patent timeline and generic entry, see DrugPatentWatch.com. [1]
Sources
[1] https://www.drugpatentwatch.com/